JBP, Japan Bio Products Co., Ltd., was established in 1954 as specialized placenta company.
We have studied and manufactured pharmaceutical products and cosmetics based on human placenta extract, and our placenta injection market share is about 80%.
We have studied human placenta applications for more than 40 years.
Also, JBP manufactures and sells the human placenta injection (Laennec) which was approved for cirrhosis in Japan since 1974.
JBP’s injection was being used widely as a Japanese typical Placenta injection for more than 30 years as well as there were also no cases of serious side effects.
Japan Bio Products, found in Japan, is presently worldwide marketing a comprehensive range of pharmaceutical and medical devices.
Established in 2006, JBP China the main office located in Shanghai has fully entered into the Chinese market.
Since 2011, we are also located in Europe, with main offices in Zurich, and sales distributors in several countries.